BIOLIGHT LIFE (Israel) Financial Indicators Patterns

We suggest you to use BIOLIGHT LIFE SCI fundamental analysis to find out if markets are today mispricing the company. In plain English you can use it to find out if BIOLIGHT LIFE SCI is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We found twenty-seven available fundamental indicators for BIOLIGHT LIFE SCI which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all BIOLIGHT LIFE SCI fundamentals including its Gross Profit, Net Income and the relationship between Revenue and EBITDA .

Chance of Financial Distress

BIOLIGHT LIFE SCI has more than 96 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

BIOLIGHT LIFE Company Summary

BIOLIGHT LIFE competes with COMPUGEN, and EVOGENE LTD. BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions comprising glaucoma, dry eye syndrome, and age-related macular degeneration. BioLight Life Sciences Ltd. was founded in 2005 and is based in Tel Aviv, Israel. BIOLIGHT LIFE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.

BIOLIGHT LIFE Number of Employees vs Return On Equity

BIOLIGHT LIFE SCI is rated third in number of employees category among related companies. It is number one stock in return on equity category among related companies reporting about  4.32  of Return On Equity per Number of Employees.

BIOLIGHT LIFE Market Fundamentals

Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
See also Trending Equities. Please also try Premium Stories module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.